Innovation & intellectual property · 12/11/2004Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Piroxicam Betadex Patent
Summary
The U.S. Patent and Trademark Office has granted a one-year extension to the term of U.S. Patent No. 4,603,123, which covers the medication Piroxicam Betadex.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →